Mylan launches generic Lopressor tablets
CANONSBURG — Mylan N.V. on Monday announced the U.S. launch of Metoprolol tartrate tablets, the generic version of Novartis’ Lopressor tablets, which are indicated for the treatment of hypertension.
The tablets in 37.5 and 75 mg strengths are the first and only available intermediate dosage strengths between the existing Metoprolol Tartrate tablet strengths of 25 mg, 50 mg and 100 mg.
Mylan currently is the only manufacturer that offers Metoprolol Tartrate tablets in five strengths.
Metoprolol Tartrate tablets 25 mg, 50 mg and 100 mg strengths had U.S. sales of approximately $68.9 million across all manufacturers for the 12 months ending Feb. 29, according to IMS Health.